A patient with a history of type 2 diabetes, hypertension, and hyperlipidemia presents with a hemoglobin A1c of 9.2%, elevated LDL cholesterol, and microalbuminuria. The healthcare team is considering the addition of an SGLT2 inhibitor to the treatment plan. Which of the following is the primary benefit of adding an SGLT2 inhibitor for this patient?

B) Provides renal protective effects

A patient with type 2 diabetes, hypertension, and hyperlipidemia presents with new lab results showing a hemoglobin A1c of 9.2%, LDL cholesterol of 160 mg/dL, triglycerides of 250 mg/dL, and microalbuminuria. Which of the following interventions should the nurse prioritize to address the patient's condition effectively?

C) Discuss the potential addition of an SGLT2 inhibitor to the treatment regimen.

A) Increase the patient's insulin dosage to improve glycemic control.

B) Educate the patient on dietary changes to reduce LDL cholesterol and triglycerides.

C) Discuss the potential addition of an SGLT2 inhibitor to the treatment regimen.

D) Focus on increasing the patient's level of physical activity to enhance cardiovascular health.

The healthcare team is considering the addition of a GLP-1 receptor agonist to the patient's regimen. Which clinical rationale supports this decision?

B) To enhance weight loss and improve glycemic control, while also addressing cardiovascular risk factors.

A) To primarily address the patient's microalbuminuria and provide renal protection.

B) To enhance weight loss and improve glycemic control, while also addressing cardiovascular risk factors.

C) To directly reduce LDL cholesterol levels and resolve the patient's tingling sensations in the feet.

D) To stabilize blood pressure further and eliminate the need for lifestyle modifications.

A patient with type 2 diabetes has recently started an SGLT2 inhibitor and intensified lifestyle modifications. The patient's hemoglobin A1c has decreased to 8.7%, but LDL cholesterol remains elevated at 150 mg/dL, and microalbuminuria persists. Which nursing intervention is most appropriate to address the patient's cardiovascular risk and renal protection?

C) Recommend the addition of an ACE inhibitor or ARB to provide renal protection and address hypertension.

A) Encourage the patient to increase their physical activity level to further reduce LDL cholesterol.

B) Discuss the potential benefits of adding a GLP-1 receptor agonist to improve glycemic control and reduce cardiovascular risk.

C) Recommend the addition of an ACE inhibitor or ARB to provide renal protection and address hypertension.

D) Focus on dietary modifications to decrease the patient's LDL cholesterol and triglycerides.

A patient with type 2 diabetes presents with increased urination, persistent thirst, and a small non-healing ulcer on the plantar surface of the right foot. Recent labs show worsening renal function and an elevated LDL cholesterol level. Which of the following interventions should the nurse prioritize to address the patient's current complications and prevent further issues?

B) Educate the patient on proper foot care and ensure a referral to a podiatrist.

A) Initiate a strict low-carbohydrate diet to improve blood glucose control.

B) Educate the patient on proper foot care and ensure a referral to a podiatrist.

C) Increase the patient's physical activity to enhance cardiovascular health.

D) Adjust the medication regimen to include an ACE inhibitor for renal protection.

A patient with diabetes presents with increased urination, persistent thirst, and a small ulcer on the plantar surface of the right foot. Recent lab results show a reduction in hemoglobin A1c to 8.4% but a worsening urine albumin-to-creatinine ratio. Which nursing intervention is most critical to prevent further complications?

B) Reinforce the need for regular foot inspections and proper footwear.

A) Educate the patient on the importance of glycemic control and medication adherence.

B) Reinforce the need for regular foot inspections and proper footwear.

C) Advise increased fluid intake to manage persistent thirst and urination.

D) Monitor blood pressure daily to assess cardiovascular risk.

During a follow-up visit, a patient with diabetes presents with a foot ulcer that has not improved despite regular care and now shows mild erythema. What is the nurse's priority action to address the suspected infection?

C) Administer a broad-spectrum antibiotic as ordered

A) Increase the frequency of dressing changes

B) Educate the patient on strict glycemic control

C) Administer a broad-spectrum antibiotic as ordered

D) Refer the patient to a wound care specialist immediately

A patient with diabetes returns for a follow-up visit. The patient's foot ulcer shows signs of mild erythema, and a wound culture is obtained while starting broad-spectrum antibiotics. Which nursing action is most appropriate to prioritize at this time to prevent further complications?

C) Monitor the patient's blood glucose levels closely to ensure optimal glycemic control.

A) Educate the patient on the importance of foot care and daily inspection of the feet.

B) Instruct the patient to discontinue the ACE inhibitor due to its effect on blood pressure.

C) Monitor the patient's blood glucose levels closely to ensure optimal glycemic control.

D) Increase the patient's physical activity to promote blood circulation to the extremities.

A patient with diabetes and elevated LDL cholesterol reports intermittent chest discomfort during physical exertion. An ECG reveals nonspecific ST-segment changes. Which nursing intervention is the most appropriate to prioritize for this patient?

C) Prepare the patient for a stress test to evaluate cardiac function

A) Educate the patient on dietary modifications to lower LDL levels

B) Instruct the patient on proper foot care to prevent ulcers

C) Prepare the patient for a stress test to evaluate cardiac function

D) Teach the patient how to monitor blood glucose levels effectively

A patient with poorly controlled diabetes presents with new chest discomfort during exertion and an ECG showing nonspecific ST-segment changes. Which nursing intervention is most appropriate to prioritize in this situation?

C) Coordinate a referral for a cardiology consultation and stress test.

A) Schedule the patient for a dietary consultation to address elevated LDL cholesterol.

B) Educate the patient on recognizing and managing hypoglycemia symptoms.

C) Coordinate a referral for a cardiology consultation and stress test.

D) Adjust the patient's insulin regimen to improve glycemic control.

Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance impairs glucose uptake by cells, leading to elevated blood glucose levels. In Type 1 Diabetes, autoimmune destruction of pancreatic beta cells results in insulin deficiency. In Type 2 Diabetes, cells become resistant to insulin, often accompanied by a relative insulin deficiency.

• Secondary mechanism: Hyperglycemia triggers the release of free fatty acids from adipose tissue, causing lipotoxicity and further impairing insulin action, creating a vicious cycle that exacerbates metabolic disturbances.

• Key complication: Persistent hyperglycemia damages blood vessels, leading to microvascular complications (retinopathy, nephropathy, neuropathy) and macrovascular complications (cardiovascular disease), increasing morbidity and mortality.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Type 2 diabetes diagnosed 10 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 40 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and tingling in feet

• Key symptoms: Blurred vision, frequent urination, increased thirst, numbness in extremities

• Vital signs: Blood pressure 148/92 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.4°F, blood glucose 210 mg/dL

Section 1

In this unfolding case study, we focus on new diagnostic results for the patient, who has been experiencing increasing fatigue and tingling in his feet. Given the patient's history of type 2 diabetes, hypertension, and hyperlipidemia, recent lab work and diagnostic tests were ordered to further evaluate his condition. The results reveal a hemoglobin A1c level of 9.2%, indicating poor long-term glycemic control. Additionally, a lipid panel shows elevated LDL cholesterol at 160 mg/dL and triglycerides at 250 mg/dL, suggesting that his hyperlipidemia is not adequately managed. Urinalysis indicates the presence of microalbuminuria, a sign of early nephropathy, which is a common complication of uncontrolled diabetes.

The new diagnostic results prompt the healthcare team to reassess the effectiveness of the current management plan. The elevated hemoglobin A1c and lipid levels, along with the presence of microalbuminuria, suggest that the patient's current treatment regimen may need to be adjusted to prevent further progression of diabetic complications. This includes considering the addition of an SGLT2 inhibitor or GLP-1 receptor agonist to improve glycemic control and potentially provide renal protective benefits. The findings also highlight the need for intensified lifestyle modifications, including dietary changes and increased physical activity, to help manage both glucose levels and cardiovascular risk factors.

These results warrant a discussion with the patient about the implications of his current health status and the importance of adherence to a revised treatment plan to mitigate the risk of further complications. The healthcare team must engage the patient in shared decision-making, emphasizing the need for regular follow-up and monitoring to ensure that any changes in therapy are effective and well-tolerated. As the case unfolds, the focus will be on evaluating the patient's response to these interventions and monitoring for any signs of new complications or improvements in his condition.

Section 2

As the healthcare team implements the revised treatment plan, the patient's response to the interventions is closely monitored. After four weeks of introducing an SGLT2 inhibitor to his regimen and intensifying lifestyle modifications, the patient returns for a follow-up appointment. During the initial assessment, the patient's vital signs reveal a blood pressure of 138/86 mmHg, which, although slightly elevated, shows a small improvement from previous readings. He reports a slight decrease in fatigue but continues to experience tingling in his feet, indicating persistent peripheral neuropathy. His weight has decreased by 3 pounds, suggesting that the dietary changes and increased physical activity are beginning to have a positive impact.

Recent lab work shows some encouraging signs: his hemoglobin A1c has decreased to 8.7%, reflecting an initial improvement in glycemic control. However, the lipid panel indicates that while the triglycerides have reduced to 220 mg/dL, the LDL cholesterol remains at 150 mg/dL, still above the target range. The persistent microalbuminuria is concerning, with the urine albumin-to-creatinine ratio slightly increased, emphasizing the need for ongoing renal monitoring and possibly adjusting his antihypertensive therapy to include an ACE inhibitor or ARB for additional renal protection.

These findings prompt the healthcare team to further refine the management plan. The partial improvement in glycemic control and weight loss are positive indicators; however, the continued presence of neuropathic symptoms and elevated LDL levels suggest that additional adjustments are necessary. The team discusses with the patient the possibility of incorporating a GLP-1 receptor agonist to further address cardiovascular risk factors and enhance glycemic management. The need for stringent adherence to lifestyle modifications is reinforced, and the importance of regular follow-up appointments is emphasized to track progress and adjust the treatment plan as needed. The patient's journey continues with an understanding of the critical role he plays in managing his condition and the support available to prevent further complications.

Section 3

Several weeks after the last follow-up, the patient presents to the clinic with new concerns that could indicate emerging complications. Although he has been diligent with his medication regimen and lifestyle adjustments, he reports experiencing increased urination and persistent thirst over the past week, despite improved blood glucose readings. On examination, his vital signs reveal a blood pressure of 142/88 mmHg, a slight increase that warrants attention. His heart rate is regular at 76 beats per minute, and his respiratory rate is normal at 16 breaths per minute. Neuropathy symptoms have not improved significantly, with tingling and numbness in his feet persisting. Of particular concern is a new finding: a small ulcer on the plantar surface of his right foot, which has not healed over the past week.

Recent lab results show a further reduction in hemoglobin A1c to 8.4%, indicating continued improvement in glycemic control. However, urinalysis reveals a worsening in the urine albumin-to-creatinine ratio, now at 35 mg/g, suggesting progressive renal involvement. The lipid panel remains unchanged, with LDL cholesterol still elevated at 148 mg/dL despite dietary modifications and pharmacotherapy. These findings prompt the healthcare team to reconsider the current management strategies, focusing on addressing the renal and cardiovascular risks more aggressively. They discuss the immediate initiation of an ACE inhibitor to provide renal protection and explore the potential benefits of intensifying the SGLT2 inhibitor dosage to further manage hyperglycemia and cardiovascular risk.

In light of the new foot ulcer, the team emphasizes the importance of proper foot care and schedules the patient for a referral to a podiatrist to prevent infection and promote healing. They reinforce the need for regular foot examinations and advise the patient on protective measures, including appropriate footwear and daily inspections. This development highlights the interconnected nature of diabetes complications, underscoring the need for a holistic and proactive approach in managing the patient's chronic condition. As the patient continues his journey, the healthcare team remains vigilant, ready to adjust the treatment plan as necessary to prevent further complications and improve quality of life.

Section 4

Several weeks later, the patient returns to the clinic for a follow-up visit. During the initial assessment, it becomes clear that while some interventions have shown promise, new challenges have emerged. The patient's blood pressure has slightly improved to 138/86 mmHg after starting the ACE inhibitor, suggesting a positive response to the medication for renal protection. However, the heart rate is now mildly elevated at 82 beats per minute, warranting further monitoring. The patient's persistent thirst and frequent urination have slightly decreased, indicating some benefit from the intensified SGLT2 inhibitor regimen, though these symptoms are not fully resolved.

The foot ulcer has become a focal point of concern. Despite diligent foot care and regular podiatric evaluations, the ulcer has not significantly improved and shows signs of mild surrounding erythema, raising the suspicion of a developing infection. A wound culture is obtained, and the patient is started on a broad-spectrum antibiotic pending results. This development underscores the importance of managing diabetes-related complications holistically, as the team emphasizes the need for strict glycemic control to promote wound healing and prevent further deterioration.

New lab results show stable kidney function with a slight improvement in the urine albumin-to-creatinine ratio, decreasing to 32 mg/g, which is encouraging. However, the LDL cholesterol remains elevated at 146 mg/dL, despite ongoing pharmacotherapy and lifestyle modifications, indicating a need to reassess the lipid management strategy. The healthcare team considers adding a PCSK9 inhibitor to the treatment plan to more effectively target cardiovascular risk. This evolving situation highlights the complexity of managing diabetes, requiring constant vigilance and adaptability in treatment strategies to address emerging complications and optimize the patient's overall health.

Section 5

During the follow-up visit, new diagnostic results reveal that the wound culture has grown Staphylococcus aureus, a finding that necessitates a switch from broad-spectrum antibiotics to a more targeted antibiotic therapy. The patient's blood glucose levels remain higher than desired, with a fasting blood glucose of 158 mg/dL and an HbA1c of 8.1%, underscoring the need for more aggressive glycemic control. The healthcare team deliberates on adjusting the patient's insulin regimen, considering the addition of a basal insulin to complement the current oral hypoglycemic agents. The patient expresses concern about the potential for hypoglycemia with insulin therapy, prompting the team to plan for comprehensive education on hypoglycemia recognition and management.

In addition to the ongoing challenges, the patient reports experiencing intermittent chest discomfort, particularly during physical exertion. This new symptom raises the suspicion of underlying cardiovascular complications, given the patient's continued elevated LDL cholesterol and diabetes-related risk factors. An electrocardiogram (ECG) is performed, indicating some nonspecific ST-segment changes, warranting further investigation with a referral for a stress test. The healthcare team emphasizes the importance of addressing these issues promptly to prevent potential acute coronary events, highlighting the interconnectedness of diabetes management and cardiovascular health.

These developments necessitate a collaborative approach to care, involving endocrinology, cardiology, and wound care specialists, to optimize the patient's treatment plan. The patient's journey continues to be a balancing act of managing multiple aspects of their health, requiring ongoing reassessment and adaptation of strategies. Through careful monitoring and timely interventions, the healthcare team aims to mitigate the risks of complications, improve quality of life, and empower the patient in their diabetes management journey.